| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |